A piece of news
The document includes four key initiatives specific to the BioRegion of Catalonia to strengthen the sector's weight in the Catalan economy and contribute to the region's reindustrialization. The proposals include: a proof-of-concept program, boosting innovative public procurement, creating a hub for emerging therapies and personalized medicine, and improving gender parity in the sector.
The Government of Catalonia and the main social and economic stakeholders of the region have approved the 2022-2025 National Pact for Industry (PNI) this September to help industry recover its weight in the Catalan economy. The executive will invest €3,270 million (€453,000 will depend on European funds) in 152 measures to relaunch and transform the Catalonia's industrial model.
Biocat has collaborated in four actions included in the Pact on innovation in health and gender parity in the sector to reinforce the sector's weight in the Catalan economy and contribute to the region's reindustrialization
Catalonia has a leading ecosystem of life sciences and healthcare innovation in Europe, with 91 research institutions and more than 1,300 companies which, despite the pandemic, have not stopped growing and advancing in their scientific and business goals. According to the latest BioRegion Report (2021), the sector already accounts for 8.7% of the Catalan GDP, employs nearly 9% of the employed population and generates €37,700 million, including companies in the sector and healthcare services. This is why "the healthcare sector plays a strategic role in Catalonia's economy", said Robert Fabregat, CEO of Biocat, who is confident that these measures "will have a transformative impact on the region's economy and society as a whole".